JP2011504099A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011504099A5 JP2011504099A5 JP2010532633A JP2010532633A JP2011504099A5 JP 2011504099 A5 JP2011504099 A5 JP 2011504099A5 JP 2010532633 A JP2010532633 A JP 2010532633A JP 2010532633 A JP2010532633 A JP 2010532633A JP 2011504099 A5 JP2011504099 A5 JP 2011504099A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- sequence
- monoclonal antibody
- sialylated
- neu5gc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20070853A FI20070853A0 (fi) | 2007-11-09 | 2007-11-09 | Glykaania sitovat monoklonaaliset vasta-aineet |
| PCT/FI2008/050643 WO2009060129A1 (en) | 2007-11-09 | 2008-11-10 | Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n-glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011504099A JP2011504099A (ja) | 2011-02-03 |
| JP2011504099A5 true JP2011504099A5 (enExample) | 2011-12-22 |
Family
ID=38786638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010532633A Pending JP2011504099A (ja) | 2007-11-09 | 2008-11-10 | シアリルルイスｃ、シアリルＴｎ、及びＮ−グリコリルノイラミン酸のエピトープに関連づけられるヒトモノクローナル抗体、ならびに前記エピトープを含む幹細胞の分析方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20100292095A1 (enExample) |
| EP (1) | EP2209809A4 (enExample) |
| JP (1) | JP2011504099A (enExample) |
| AU (1) | AU2008324073A1 (enExample) |
| CA (1) | CA2743032A1 (enExample) |
| FI (1) | FI20070853A0 (enExample) |
| WO (1) | WO2009060129A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20095418A0 (fi) * | 2009-04-16 | 2009-04-16 | Suomen Punainen Risti Veripalv | Kryptinen subpopulaatio |
| EP2345964A4 (en) * | 2008-10-13 | 2013-11-20 | Mitsubishi Electric Corp | CONTRACTING APPROACH, OPERATING PROGRAM, RECORDING MEDIUM AND CONTRACTING PROCESS |
| WO2013151649A1 (en) | 2012-04-04 | 2013-10-10 | Sialix Inc | Glycan-interacting compounds |
| PL2928476T3 (pl) | 2012-12-07 | 2018-07-31 | Glycomimetics, Inc. | Związki, kompozycje i sposoby wykorzystujące antagonistów e-selektyny do mobilizacji komórek hematopoietycznych |
| US9879087B2 (en) | 2014-11-12 | 2018-01-30 | Siamab Therapeutics, Inc. | Glycan-interacting compounds and methods of use |
| EP3218005B1 (en) | 2014-11-12 | 2023-01-04 | Seagen Inc. | Glycan-interacting compounds and methods of use |
| PT3227310T (pt) | 2014-12-03 | 2019-11-06 | Glycomimetics Inc | Inibidores heterobifuncionais de e-selectinas e recetores de quimiocina cxcr4 |
| EP3371222A1 (en) * | 2015-11-03 | 2018-09-12 | GlycoMimetics, Inc. | Methods and compositions for the production of monoclonal antibodies, hematopoietic stem cells, and methods of using the same |
| WO2017083582A1 (en) | 2015-11-12 | 2017-05-18 | Siamab Therapeutics, Inc. | Glycan-interacting compounds and methods of use |
| US11291678B2 (en) | 2016-03-02 | 2022-04-05 | Glycomimetics, Inc | Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin |
| US11433086B2 (en) | 2016-08-08 | 2022-09-06 | Glycomimetics, Inc. | Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4 |
| CN109890421B (zh) | 2016-10-07 | 2023-10-20 | 糖模拟物有限公司 | 高效的多聚体e-选择蛋白拮抗剂 |
| US11401330B2 (en) | 2016-11-17 | 2022-08-02 | Seagen Inc. | Glycan-interacting compounds and methods of use |
| GB201703212D0 (en) * | 2017-02-28 | 2017-04-12 | Nat Univ Ireland Galway | The detectionm quantification and discrimination of the sialic acid N-glycolylneuraminic (Neu5Gc) acid and N-acetylneuraminic acid (Neu5gc) |
| CA3054939A1 (en) | 2017-03-03 | 2018-09-07 | Seattle Genetics, Inc. | Glycan-interacting compounds and methods of use |
| JP7272956B2 (ja) | 2017-03-15 | 2023-05-12 | グリコミメティクス， インコーポレイテッド | Ｅ－セレクチンアンタゴニストとしてのガラクトピラノシル－シクロヘキシル誘導体 |
| JP7275131B2 (ja) | 2017-11-30 | 2023-05-17 | グリコミメティクス， インコーポレイテッド | 骨髄浸潤リンパ球を動員する方法、およびその使用 |
| KR20200104889A (ko) | 2017-12-29 | 2020-09-04 | 글리코미메틱스, 인크. | E-셀렉틴 및 갈렉틴-3의 이종이기능성 억제제 |
| PT110526B (pt) * | 2018-01-26 | 2021-02-04 | Univ Nova De Lisboa | Anticorpo, fragmento funcional ou sonda do mesmo contra antigénios tumorais |
| CA3091454A1 (en) | 2018-03-05 | 2019-09-12 | Glycomimetics, Inc. | Methods for treating acute myeloid leukemia and related conditions |
| BR112021004444A2 (pt) * | 2018-09-10 | 2021-06-01 | Cold Spring Harbor Laboratory | métodos para tratar pancreatite |
| US11845771B2 (en) | 2018-12-27 | 2023-12-19 | Glycomimetics, Inc. | Heterobifunctional inhibitors of E-selectin and galectin-3 |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4342566A (en) * | 1980-02-22 | 1982-08-03 | Scripps Clinic & Research Foundation | Solid phase anti-C3 assay for detection of immune complexes |
| US4965198A (en) * | 1985-12-24 | 1990-10-23 | Konica Corporation | Monoclonal antibody and method of manufacturing hybridoma producing the same |
| US4949778A (en) * | 1987-12-16 | 1990-08-21 | Kawasaki Steel Corporation | Immersion nozzle for continuous casting |
| DE4208795A1 (de) * | 1992-03-19 | 1993-09-23 | Behringwerke Ag | Monoklonaler anti-gangliosid-antikoerper, seine herstellung und verwendung als tumortherapeutikum |
| EP2261255A1 (en) * | 2003-07-15 | 2010-12-15 | The Regents of The University of California | Methods for purifying sialic acid-specific antibodies and composition comprising affinity-purified antibodies |
| FI20055398A0 (fi) * | 2005-07-08 | 2005-07-08 | Suomen Punainen Risti Veripalv | Menetelmä solupopulaatioiden evaluoimiseksi |
| WO2007054622A1 (en) * | 2005-11-08 | 2007-05-18 | Suomen Punainen Risti, Veripalvelu | Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof |
| AU2007264846A1 (en) * | 2006-06-29 | 2008-01-03 | Glykos Finland Oy | Novel cellular glycan compositions |
| WO2008087259A1 (en) * | 2007-01-18 | 2008-07-24 | Suomen Punainen Risti, Veripalvelu | Novel carbohydrate profile compositions from human cells and methods for analysis and modification thereof |
| US20100047827A1 (en) * | 2007-01-18 | 2010-02-25 | Suomen Punainen Risti, Veripalvelu | Novel specific cell binders |
| CA2712556A1 (en) * | 2007-01-18 | 2008-07-24 | Glykos Finland Ltd | Novel carbohydrate from human cells and methods for analysis and modification thereof |
-
2007
- 2007-11-09 FI FI20070853A patent/FI20070853A0/fi not_active Application Discontinuation
-
2008
- 2008-11-10 US US12/741,987 patent/US20100292095A1/en not_active Abandoned
- 2008-11-10 EP EP08847066A patent/EP2209809A4/en not_active Withdrawn
- 2008-11-10 CA CA2743032A patent/CA2743032A1/en not_active Abandoned
- 2008-11-10 AU AU2008324073A patent/AU2008324073A1/en not_active Abandoned
- 2008-11-10 WO PCT/FI2008/050643 patent/WO2009060129A1/en not_active Ceased
- 2008-11-10 JP JP2010532633A patent/JP2011504099A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011504099A5 (enExample) | ||
| Saeed et al. | Antibody engineering for pursuing a healthier future | |
| JP2011504099A (ja) | シアリルルイスｃ、シアリルＴｎ、及びＮ−グリコリルノイラミン酸のエピトープに関連づけられるヒトモノクローナル抗体、ならびに前記エピトープを含む幹細胞の分析方法 | |
| Linman et al. | Surface plasmon resonance study of protein− carbohydrate interactions using biotinylated sialosides | |
| HRP20250850T1 (hr) | Antitijela protiv claudina 18.2 korisna u dijagnozi raka | |
| JP2009533021A5 (enExample) | ||
| WO2013054331A8 (en) | Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam) | |
| NZ717429A (en) | Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly | |
| JP2013507970A5 (enExample) | ||
| RU2013142334A (ru) | КОМПОЗИЦИИ И СПОСОБЫ ПРИМЕНЕНИЯ ДЛЯ ОПРЕДЕЛЕНИЯ НЕ4а | |
| DK2054443T3 (da) | Antistoffer mod en epitop fra AGR2, assays og hybridomer | |
| WO2005010485A3 (en) | Methods for detecting and analyzing n-glycolylneuraminic acid (neu5gc) in biological materials | |
| MX2025004565A (es) | Anticuerpos anti-cd3 dependientes de ph y metodos relacionados con estos | |
| CN108064342A (zh) | 用于检测干细胞的方法及试剂盒 | |
| JP7424718B2 (ja) | 抗原の処理方法。 | |
| RU2009124225A (ru) | Мышиные моноклональные антитела, связывающиеся с антигеном f1 из yersinia pestis, способ их получения с использованием дрожжей, способ и набор для детекции yersinia pestis | |
| CA3115887A1 (en) | Antibodies specific for glycosylated apoj and uses thereof | |
| US20110045497A1 (en) | Novel acidic glycan markers of human cells | |
| US8043852B2 (en) | Monoclonal antibody specific to dentin-derived heparan sulfate | |
| JP2024513880A (ja) | 免疫組織化学法およびｋｉｒ３ｄｌ２特異的薬剤 | |
| JP5711877B2 (ja) | 癌の悪性度の検知方法及び癌の悪性度の診断剤 | |
| ATE476449T1 (de) | Verwendung von endosialinbindenden proteinen zum isolieren endosialinpositiver zellen | |
| EA201490286A1 (ru) | Моноклональные антитела, специфичные в отношении x-37 бета-амилоида, и пути их применения | |
| JP7366411B2 (ja) | ヒトαディフェンシンＨＤ５を検出する方法及びキット、並びにこれらにおいて用いられる抗体 | |
| JP2020162572A (ja) | 抗原の処理方法。 |